Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.
Ferrario C, Mackey J, Gelmon KA, Levasseur N, Sorensen PH, Oo HZ, Negri GL, Tse VWL, Spencer SE, Cheng G, Morin GB, Del Rincon S, Cotechini T, Gonçalves C, Hindmarch CCT, Miller WH Jr, Amiri M, Basiri T, Villareal-Corpuz V, Sperry S, Gregorczyk K, Spera G, Sonenberg N, Pollak M.
Ferrario C, et al. Among authors: levasseur n.
Clin Cancer Res. 2025 Feb 3;31(3):491-502. doi: 10.1158/1078-0432.CCR-24-0841.
Clin Cancer Res. 2025.
PMID: 39576211
Clinical Trial.